Literature DB >> 6520837

Persistent immunoglobulin deficiency after prednisolone and antiepileptic therapy in a C2 deficient patient with lupus-like syndrome.

P Woo, R S Pereira, A M Lever.   

Abstract

A homozygous C2 deficient patient with a lupus-like syndrome developed hypogammaglobulinemia soon after treatment with prednisolone together with phenytoin, replaced subsequently by carbamazepine. She suffered from recurrent chest infections and her lupus symptoms continued unabated. In vitro tests of immunoglobulin production by her Epstein Barr virus transformed B cells showed typical patterns of reduced IgA and IgG production seen in common variable hypogammaglobulinemia. An opsonisation defect to Hemophilus influenzae was also demonstrated which could be reversed by the addition of pooled human gammaglobulin. Serum IgM and IgG levels returned to normal 2 years after withdrawal of phenytoin and prednisolone, but 3 years later, she remained IgA deficient and the in vitro abnormalities persisted.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6520837

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  4 in total

1.  IgG2, IgG4 and IgA deficiency possibly associated with carbamazepine treatment.

Authors:  Zenichiro Kato; Mizuho Watanabe; Naomi Kondo
Journal:  Eur J Pediatr       Date:  2003-01-25       Impact factor: 3.183

Review 2.  Selective IgA deficiency in autoimmune diseases.

Authors:  Ning Wang; Nan Shen; Timothy J Vyse; Vidya Anand; Iva Gunnarson; Gunnar Sturfelt; Solbritt Rantapää-Dahlqvist; Kerstin Elvin; Lennart Truedsson; Bengt A Andersson; Charlotte Dahle; Eva Ortqvist; Peter K Gregersen; Timothy W Behrens; Lennart Hammarström
Journal:  Mol Med       Date:  2011-08-04       Impact factor: 6.354

Review 3.  Infectious diseases associated with complement deficiencies.

Authors:  J E Figueroa; P Densen
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

4.  Development of common variable immunodeficiency in IgA- and IgG2-deficient patients with systemic lupus erythematosus.

Authors:  Kazuhide Suyama; Yukihiko Kawasaki; Yusaku Abe; Masahiro Watanabe; Shinichiro Ohara; Tomoko Oikawa; Nobuko Sakai; Kouichi Hashimoto; Mitsuaki Hosoya
Journal:  Pediatr Nephrol       Date:  2011-12-30       Impact factor: 3.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.